Whole genome sequencing is being introduced as a standard of care for glioma patients in two neurosurgical oncology centres in the West Midlands. The introduction of whole genome sequencing is part of a broader trend of its increasing use in various medical fields, including oncology and rare disease diagnosis. Its application is being explored and studied in different contexts, including its potential impact on diagnosis, management, and screening in healthcare settings.